Aman Chauhan, Associate Professor at University of California, San Francisco, shared Amol Akhade’s Senior Consultant Medical Oncologist and Hemato-Oncologist at Fortis Hospitals Mumbai, post on LinkedIn, adding:
”Join us virtually on August 26 for a lively discussion on What’s New in Neuroendocrine Oncology!
From NET G3 vs NEC and lung NETs to PRRT, sequencing, DLL3, immunotherapy, and what’s coming next, we’ll tackle 10 practical and timely topics.
Registration is free and open to all!
Qutoing Amol Akhade’s post:
”Ten Topics that we will cover in panel discussion for NET during 12 th OncoWisdom webinar on 26 th August 2026 at 7.30 pm IST .
Along with this we will cover all major NET trials( Netter 1 , Netter 2, Cabinet and others) in presentation at the beginning.
Do Register if u have not yet done
We already have 150 plus registrations for this common but rarely discussed topic.”
Amol Akhade was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
Other articles featuring Aman Chauhan on OncoDaily.